HIV-1 Tat and Viral Latency: What We Can Learn from Naturally Occurring Sequence Variations.
about
Screening of an FDA-approved compound library identifies levosimendan as a novel anti-HIV-1 agent that inhibits viral transcription.Implication of Different HIV-1 Genes in the Modulation of Autophagy.Long Noncoding RNA uc002yug.2 Activates HIV-1 Latency through Regulation of mRNA Levels of Various RUNX1 Isoforms and Increased Tat Expression.Cellular RelB interacts with the transactivator Tat and enhance HIV-1 expression
P2860
HIV-1 Tat and Viral Latency: What We Can Learn from Naturally Occurring Sequence Variations.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
HIV-1 Tat and Viral Latency: W ...... Occurring Sequence Variations.
@en
HIV-1 Tat and Viral Latency: W ...... Occurring Sequence Variations.
@nl
type
label
HIV-1 Tat and Viral Latency: W ...... Occurring Sequence Variations.
@en
HIV-1 Tat and Viral Latency: W ...... Occurring Sequence Variations.
@nl
prefLabel
HIV-1 Tat and Viral Latency: W ...... Occurring Sequence Variations.
@en
HIV-1 Tat and Viral Latency: W ...... Occurring Sequence Variations.
@nl
P2860
P356
P1476
HIV-1 Tat and Viral Latency: W ...... Occurring Sequence Variations
@en
P2093
Doreen Kamori
P2860
P356
10.3389/FMICB.2017.00080
P577
2017-01-30T00:00:00Z